Aventis Pasteur MSD
8, rue Jonas Salk
69367 Lyon cedex 07
France
Tel: +33 437 284 000
Fax: +33 437 284 400
Website: www.aventis-pasteur-msd.com

Aventis Pasteur MSD is committed to the improvement of public health in Europe: by offering the most complete range of vaccines, affording lifelong protection to those vaccinated, by simplifying vaccination in order to improve vaccine cover, through developing understanding in the field of vaccinology for more effective preventive medicine. Last autumn, a new hexavalent vaccine, Hexavac® was approved throughout Europe and first commercialised in Germany. This highly innovative vaccine combines Diphtheria, Tetanus, Acellular Pertussis, Poliomyelitis, Haemophilus influenzae type b and Hepatitis B, in just one 0,5 ml injection.

Baxter Vaccine AG
Industriestrasse 67
A-1221 Wien
Austria
Tel: +43 1 20100 0
Fax: +43 1 20100 599

Chiron Vaccines
Chiron Behring GmbH & Co
P.O. Box 16 30
D - 35006 Marburg
Germany
Tel: +49 6421 395 944
Fax: +49 6421 392 336
E-mail: thomas.schick@chiron-behring.com

Chiron Vaccines produces and distributes more than 25 viral and bacterial vaccines, addressing serious diseases that affect the health of infants and adolescents.
Our multinational, fundamental research recently resulted in preventive vaccines against the bacterial meningitis pathogens Meningococcus C (Menjugateâ) and Haemophilus influenzae B (Vaxemâ Hib). Being one of the world's leaders in innovative vaccines, Chiron Vaccines offers a highly purified influenza vaccine produced according to the latest technology (Agrippalâ) and the first preservative free influenza vaccine (Begrivacâ). As a major supplier of oral poliomyelitis (Polioral) and mumps, measles, rubella vaccine (Moruparâ) world wide, Chiron Vaccines also contributes to the WHO objectives in eradicating some of these diseases.

GlaxoSmithKline Biologicals
89 Rue de L'Institut
1330 Rixensart
Belgium
Tel: +32 2 656 8111
Fax: +32 2 656 8000

GlaxoSmithKline Biologicals, the world's leading vaccine manufacturer, is located in Rixensart, Belgium. Rixensart is the centre of all GlaxoSmithKline's activities in the field of vaccine research, development and production. GSK Biologicals employs over 700 research scientists who are devoted to discovering new vaccines and developing more cost-effective and convenient combination products to prevent infections which cause serious medical problems worldwide. GSK distributes over 770 million doses of vaccines per year for the developing and developed world. Every second, 25 doses of GSK Biologicals vaccines are distributed to 160 countries around the world. For information, visit GlaxoSmithKline's vaccine website at http://www.worldwidevaccines.com.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Pfizer Inc.
235 East 42nd Street
New York, NY 10017-5755
USA
Tel: +1 212 573 2678
Fax: +1 212 309 4579
E-mail: hornd1@pfizer.com

Zithromax (azithromycin) is an effective antibiotic for a range of pediatric URTIs. Its once-daily dosing regimen, short course of therapy and favorable side-effect profile, make it a suitable medication for children.
Diflucan (fluconazole) is used to treat oral thrush. It is also used in immunocompromised children to treat esophageal and systemic candidiasis, and cryptococcal meningitis.
Unasyn is a combination of ampicillin and sulbactam (beta-lactamase inhibitor) and is effective in a wide range of pediatric infections.
All three products are available in pleasant-tasting suspensions for pediatric use.

Statens Serum Institute
5, Artillerivej
DK-2300 Copenhagen S
Denmark
Tel: +45 3268 3268
Fax: +45 3268 3868
E-mail: serum@ssi.dk
Website: www.ssi.dk

The Danish Government established Statens Serum Institute in 1902. At that time, diphtheria was a serious threat to the population of Denmark and the initial task was to manufacture adequate supplies of diphtheria antitoxin from horse serum. Activities were soon extended to diagnosis of infectious diseases, epidemiology, microbiology, and vaccine production. Based on a strong research tradition within these fields, Statens Serum Institute has over a time span of almost 100 years gained experience and expertise in combining these disciplines. By further expanding into immunology and molecular biology, Statens Serum Institute has obtained a unique combination of knowledge from which the present core competencies are nourished.

Wyeth Lederle Vaccines
Wyeth-Ayerst Global Pharmaceuticals
280 King of Prussia Road
Radnor, PA 19087
USA
Tel: +1 610 902 4100
Fax: +1 610 989 5707
Website: www.wyeth.com

Wyeth Lederle Vaccines is recognized internationally as a leader in the discovery, development, manufacture, and marketing of a broad range of paediatric and adult vaccine products. Working with physicians, governments and public health agencies as a trusted partner, the company helps support health policies around the world. As a leader in the field, Wyeth Lederle Vaccines will continue to invest in the future of disease prevention, with many new vaccines currently in development.